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Cerebellar ataxias: β-III spectrin’s interactions suggest
common pathogenic pathways
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Abstract Spinocerebellar ataxias (SCAs) are a genetically heterogeneous group of disorders all
characterised by postural abnormalities, motor deficits and cerebellar degeneration. Animal and
in vitro models have revealed β-III spectrin, a cytoskeletal protein present throughout the soma
and dendritic tree of cerebellar Purkinje cells, to be required for the maintenance of dendritic
architecture and for the trafficking and/or stabilisation of several membrane proteins: ankyrin-R,
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cell adhesion molecules, metabotropic glutamate receptor-1 (mGluR1), voltage-gated sodium
channels (Nav) and glutamate transporters. This scaffold of interactions connects β-III spectrin
to awide variety of proteins implicated in the pathology ofmany SCAs.Heterozygousmutations in
the gene encoding β-III spectrin (SPTBN2) underlie SCA type-5 whereas homozygousmutations
cause spectrin associated autosomal recessive ataxia type-1 (SPARCA1), an infantile form of
ataxia with cognitive impairment. Loss-of β-III spectrin function appears to underpin cerebellar
dysfunction and degeneration in both diseases resulting in thinner dendrites, excessive dendritic
protrusionwith loss of planarity, reduced resurgent sodium currents and abnormal glutamatergic
neurotransmission. The initial physiological consequences are a decrease in spontaneous activity
and excessive excitation, likely to be offsetting each other, but eventually hyperexcitability gives
rise to dark cell degeneration and reduced cerebellar output. Similar molecular mechanisms have
been implicated for SCA1, 2, 3, 7, 13, 14, 19, 22, 27 and 28, highlighting alterations to intrinsic
Purkinje cell activity, dendritic architecture and glutamatergic transmission as possible common
mechanisms downstream of various loss-of-function primary genetic defects. A key question for
future research is whether similar mechanisms underlie progressive cerebellar decline in normal
ageing.
(Received 26 June 2015; accepted after revision 14 December 2015; first published online 28 January 2016)
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Abstract figure legend β-III spectrin is implicated in a number of cellular processes that are essential for maintaining
normal Purkinje cell physiology. Disruption to protein trafficking (1), alterations to intrinsic Purkinje cell firing (2),
dendritic architecture (3) and glutamatergic neurotransmission (4) have all been identified as common mechanisms
across various SCAs.
Introduction
The cerebellum is essential for maintaining postural
control and coordination of voluntary muscle movement
(Manto, 2008). Purkinje cells, the principal neurons
and sole output of the cerebellar cortex, exhibit auto-
nomous high-frequency repetitive firing in addition to
receiving input from inhibitory interneurons and two
excitatory fibres, climbing and parallel fibres. Purkinje
cells integrate the information and transmit timing signals
essential for motor coordination in the form of inhibitory
inputs to the deep cerebellar nuclei (DCN). The DCN,
in turn, communicate with various parts of the nervous
system controlling movement. Alterations to Purkinje cell
and consequently DCN activity (Shakkottai et al. 2004)
are therefore sufficient to induce ataxia, a phenotype
characterised by gait disturbances, postural instability and
motor incoordination.
Autosomal dominant spinocerebellar ataxias (SCAs),
a heterogeneous group of inherited neurodegenerative
disorders, are a major cause of cerebellar ataxia. Their
prevalence in several populations can be as high as
5–6 in 100,000 (Ruano et al. 2014), similar to that of
Huntington’s and motor neuron disease. All SCAs can
be characterised by postural abnormalities, progressive
motor incoordination and cerebellar degeneration, but a
number of subtypes can also be associated with additional
neurological features such as cognitive impairment. To
date 40 different genomic loci, numbered in order of
discovery, have been associated with SCAs and the genes
involved, along with the responsible mutations, have been
identified for 26 SCA subtypes.
The first genetic defects to be identified as associating
with SCA1, 2, 3, 6, 7 and 17 were coding for CAG repeat
expansions, leading to proteins with abnormally long
poly-glutamine (polyQ) tracts (Orr et al. 1993; Kawaguchi
et al. 1994; Imbert et al. 1996; Pulst et al. 1996; Sanpei et al.
1996; David et al. 1997; Zhuchenko et al. 1997; Nakamura
et al. 2001). Together they account for more than half
of all SCA cases, with SCA3 being the most common
(Ruano et al. 2014). Subsequently, non-coding CAG
repeats (Holmes et al. 1999; Koob et al. 1999), non-CAG
repeat expansions (Matsuura et al. 2000; Sato et al. 2009;
Kobayashi et al. 2011) and, more recently, conventional
mutations have been found to underlie different SCA sub-
types (Table 1). This latter category is ever expanding, due
to the advent of whole-exome sequencing, and although
conventional mutations are often associated with rarer
forms of SCA, they have provided substantial insight into
the physiological defects underlying ataxia.
The focus of this review is genetic analyses and use
of experimental models to elucidate the pathogenesis
of spinocerebellar ataxia type 5 (SCA5). Evidence will
be presented demonstrating how changes in Purkinje
cell intrinsic excitability, dendritic architecture and
synaptic function, observed in mouse models of SCA5,
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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have contributed to our understanding of cerebellar
dysfunction in SCA5 andhow similar physiological defects
may be associated with other SCAs.
Heterozygous mutations in SPTBN2 gene give rise to
spinocerebellar ataxia type 5
Thegenetic locus for SCA5wasmapped to the centromeric
region of the long arm of chromosome 11 (11q13) using
a large kindred descended from the paternal grandparents
of United States President Abraham Lincoln (Ranum et al.
1994). Later a French (Stevanin et al. 1999) and a German
(Burk et al. 2004) pedigree with a similarly mild form
of SCA were linked to the same chromosomal region.
Mutations were subsequently identified in the SPTBN2
gene encoding β-III spectrin (Fig. 1A; Ikeda et al. 2006),
which is found throughout the cell body and dendritic tree
of Purkinje cells (Jackson et al. 2001).
The initial symptoms of SCA5 are disturbance of gait,
incoordination of limbs, abnormal eye movements and
slurred speech. Yet age of onset is variable within families,
starting between the second and seventh decade. Typically
there is no reduction in lifespan, possibly due to the lack
of bulbar paralysis which in other SCAs appears to result
in a poorer ability to fight recurrent pneumonia (Zoghbi,
1991) and patients remain ambulatory for several decades.
Pathologically severe atrophyof the cerebellum is observed
with magnetic resonance imaging (MRI) and autopsy
examination shows significant Purkinje cell loss, shrinkage
of the molecular layer, mild loss of granular neurons and
empty basket fibres (Ikeda et al. 2006).
Infantile ataxia and cognitive impairment associated
with mutations in SPTBN2
Homozygous mutations in SPTBN2 were recently found
in two families with both cerebellar ataxia from childhood
and cognitive impairment (Fig. 1B), classifying an
allelic condition, spectrin associated autosomal recessive
cerebellar ataxia type 1 (SPARCA1) (Lise et al. 2012;
Elsayed et al. 2014). A complete loss-of β-III spectrin
function is thus implicated inmotor and cognitive deficits
from birth. However, a novel heterozygous mutation
(R480W) has also been reported in a patient exhibiting
infantile onset and global developmental delay (Jacob et al.
2012). It may be that in this case there is an undetected
mutation in trans or an environmental modifier resulting
in a much earlier and more severe phenotype than
actin binding domain
L253P
A
B R480W
C627X T955ins120X
5 bp del
G1952ins27X
8 bp del
ΔELQKVFQDLLYLM
ΔLAATR634W
ΔE870
T472M N1224S R1880H E2084L
seventeen spectrin repeats
Pleckstrin
homology
domain
Figure 1. Structure of β-III spectrin and localisation of mutations
A, β-III spectrin comprises an N-terminal actin binding domain, 17 spectrin repeats and a pleckstrin homology (PH)
domain at the C-terminus, which can facilitate interaction with the lipid bilayer. Mutations associated with SCA5
are indicated: missense mutation (L253P) within second calponin-homology (CH) domain, German family (Ikeda
et al. 2006); missense mutation (T472M) within second spectrin repeat, Norwegian family (Cho & Fogel, 2013);
39 bp in-frame deletion (39) resulting in 13-amino-acid deletion (E532_M544del) within third spectrin repeat,
Lincoln pedigree (Ikeda et al. 2006); 15 bp in-frame deletion (L629_R634) and missense mutation (R634W), French
family (Ikeda et al. 2006); 3 bp in-frame deletion resulting in glutamic acid deletion (E870del) in sixth spectrin
repeat, Japanese family (Wang et al. 2014). Co-segregation of mutations N1224S, R1880H and E2804L with ataxia
is uncertain (Zu¨hlke et al. 2007). B, location of mutations associated with infantile cerebellar ataxia: heterozygous
R480W mutation identified in two cases of infantile ataxia with global developmental delay (Jacob et al. 2012;
Parolin Schnekenberg et al. 2015); homozygous stop codon (C627X) within third spectrin repeat, UK family
(Lise et al. 2012); homozygous 5 bp frameshift deletion (T955ins120X) in spectrin repeat 6, Egyptian family
(Elsayed et al. 2014). Homozygous 8 bp frameshift deletion (G1952ins27X) in spectrin repeat 16, Beagle puppies
(Forman et al. 2012).
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Table 2. Molecular, anatomical and behavioural characteristics of mouse lines generated to model SCA5
Spnb3−/− β-III−/− Pcp2-tTA+/−/TRE-SP39+/−
(Stankewich et al. 2010) (Perkins et al. 2010) (Armbrust et al. 2014)
Protein expressed Truncated β-III spectrin,
terminating at start of spectrin
repeat 14
β-III spectrin lacking exons 2–6
(actin binding domain)
Full complement of mouse
β-lll spectrin. Human
39β-III spectrin
Protein distribution Mislocalised to axon initial
segment
Normal somatodendritic
distribution
Normal somatodendritic
distribution
Motor defects Slightly poorer performance on
rotarod at 8 months of age. Not
progressive
Progressive ataxia with mild motor
impairment at 3 weeks of age.
By 6 months of age unable to
stay on rotarod at 3 r.p.m.
Mild impairment on rotarod
at 26 weeks of age. Later
time points not analysed
Cerebellar
degeneration
Thinning of molecular layer at 8
months. No PC loss at 1.5 years
ML thinning and PC loss visible by 6
months, greater at 1 year
Thinning of ML at 80 weeks.
No PC loss
Unexpected
phenotype
Myoclonic seizures. Muscle
weakness
None None
other β-III spectrin heterozygousmutations. Alternatively
residue R480, within spectrin repeat 2, could be of
particular structural importance. Notably, the same
heterozygous R480Wmutationwas recently identified in a
childoriginally given aworkingdiagnosis of ataxia cerebral
palsy (Parolin Schnekenberg et al. 2015), strengthening the
evidence that mutation R480W is more deleterious than
other heterozygous SPTBN2mutations.
Variability in presentation has similarly been observed
for mutations in other SCA-associated loci. Mutations
in the inositol 1,4,5-trisphosphate receptor type 1 gene
(ITPR1) have been reported in families with late onset
SCA15 (van de Leemput et al. 2007), early-onset
SCA29 (Iwaki et al. 2008) and sporadic infantile-onset
cerebellar ataxia (Huang et al. 2012). Mutations in the
genes KCNC3 (Waters et al. 2006; Parolin Schnekenberg
et al. 2015) and FGF14 (Coebergh et al. 2014; Planes
et al. 2015) have also been associated with variable
phenotypes. The molecular reason(s) for differences
in timing of onset remain unknown, but the clinical
characteristics of patients with early-onset disease are
generally non-progressive ataxia, motor developmental
delay and mild cognitive deficits. Understanding the
molecularmechanismswhereby early-onset cases of ataxia
are associated with cognitive impairment could help
addresswhether the cerebellumplays a developmental role
in cognition or if the deficits are non-cerebellar in origin.
Loss-of protein function in cerebellar pathogenesis
Animal models have proved instrumental in elucidating
the pathogenesis of SCA. To date three different SCA5
mouse models have been generated and analysed for signs
of motor incoordination and cerebellar degeneration in
relation to disrupted β-III spectrin function (Table 2).
Two mouse models were created by gene disruption,
one by exon trapping (Spnb3−/−; Stankewich et al.
2010) and the other by targeted recombination (β-III−/−;
Perkins et al. 2010). The third is a conditional trans-
genic model which utilises the tetracycline transactivator
protein (tTA) under the control of the Purkinje cell
specific promoter Pcp2 to specifically drive wild-type or
39 β-III spectrin in cerebellar Purkinje cells (Armbrust
et al. 2014). All three models exhibit motor impairment
but only the β-III−/− mouse model recapitulates the
progressive motor deficits and Purkinje cell loss observed
in SCA5 patients (Perkins et al. 2010). The β-III−/−
mouse model in particular has implicated neuronal
dysfunction in the early motor phenotype with gait
and coordination deficits evident prior to any cerebellar
degeneration. It, together with the identification of the
allelic condition SPARCA1, has also provided insights into
the molecular dominance in SCA5. Results suggest the
disease is due to loss-of-function but not due to β-III
spectrin haploinsufficiency as no phenotype is observed
in 2-year-old heterozygous (β-III+/−)mice (Clarkson et al.
2010) or elderly heterozygous SPARCA1carriers (Lise et al.
2012). Instead SCA5 pathogenesis is likely to occur when
β-III spectrin function falls below 50% of wild-type level
due to interference by mutant protein.
Loss-of protein functions due to dominant-negative
effects have also been reported for a number of other
SCA subtypes (Table 1). Knock-out animals therefore
have the potential to mirror disease phenotypes of
autosomal dominant SCAs more faithfully than trans-
genic models. However, full characterisation for the pre-
sence of truncated proteins that could either abrogate
loss-of protein function or confer an aberrant function
is essential, as is functional analysis to validate models
as true knockouts. Creation of representative transgenic
models also requires, in order to avoid gene dosage effects
on phenotype, detailed information regarding the stability
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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and expression level of mutant proteins and theminimum
level ofwild-type protein critical for normal function. This
is highlighted by work using Drosophila models of SCA5
where progressive neurodegeneration was observed in the
Drosophila eye when human β-III spectrin containing
either the German (L253P) or American (39) mutation
was ectopically overexpressed (Lorenzo et al. 2010). The
phenotype, however, was milder in flies hemizygous for
L253P spectrin, with these flies expressing significantly
lower levels of transgenic protein than flies expressing
39 spectrin. The phenotype could be enhanced by
increasing L253P spectrin expression through creation of
homozygous flies. Similarly posterior paralysis was only
observed in larvae expressing a single copy of human39
spectrin when one copy of the endogenous β-spectrin
gene was silenced. Hopefully with the advent of new
gene targeting technologies (TALENs, Crispr/Cas9) the
creation of knock-in models will be greatly facilitated,
circumventing caveats surrounding level of transgene
expression for loss-of-function models.
Common molecular mechanisms underpinning
cerebellar dysfunction in SCAs
Analyses of the different animal models and a number
of in vitro studies have implicated various molecular
mechanisms in the cerebellar dysfunction associated with
SCA5. In particular they converge on alterations to
glutamatergic transmission and Purkinje cell excitability,
arising from a role for β-III spectrin in membrane protein
trafficking, localisation and stabilisation. Disruption to
these same physiological processes is evident in models
of other SCAs, highlighting the possible convergence of
common mechanisms in cerebellar ataxia.
Disruption in membrane protein trafficking, localisation
and/or stabilisation. The actin binding domain and
C-terminus of β-III spectrin (Fig. 2A) were both shown in
a yeast two-hybrid assay to directly bind toArp 1 (Holleran
et al. 2001), a subunit of the dynactin complex which
mediates the association of vesicular cargowith themicro-
tubule motor dynein (Karki et al. 2000). Further support
for β-III spectrin’s role in protein vesicular trafficking
is the co-purification from rat brain vesicles with Arp1
and dynein (Holleran et al. 2001) and disruption to
axonal transport in flies expressing either the American
or German mutant β-III spectrin, with enhancement of
these transport abnormalities in dynein and dynactin
loss-of-function mutants (Lorenzo et al. 2010). Both
β-III spectrin knockout (Spnb3−/− and β-III−/−) mouse
lines also exhibit dilatation of endoplasmic reticulum and
alterations to Golgi structure indicating an important
function of β-III spectrin in the trafficking of membrane
proteins (Perkins et al. 2010; Stankewich et al. 2010).
It has been shown that β-III spectrin interacts directly
with the carboxy-terminus of EAAT4 (Fig. 2A; Jackson
et al. 2001), the glutamate transporter found in Purkinje
cell soma and dendrites (Yamada et al. 1996; Dehnes
et al. 1998). The interaction stabilises EAAT4 at the
plasma membrane, resulting in an increase in cell surface
expression and enhanced glutamate uptake (Jackson et al.
2001). In contrast, mutant 39 β-III spectrin failed to
restrict the lateral mobility of EAAT4 in HEK 293 cells
indicating an inability to properly anchor EAAT4 at the
plasma membrane (Ikeda et al. 2006). Co-expression of
mutant L253P β-III spectrin in HEK 293 cells was also
found to disrupt post-Golgi trafficking of EAAT4, with
normal cell surface expression only attainable when cells
were incubated at a lower temperature (Clarkson et al.
Ankyrin based complexes
Ankyrin R
Arp1mGluR1
EAAT4
EAAT4Δ11FL- EAAT4
B B´ C C´
Arp1/4.1
A
Figure 2. Defective protein trafficking when β-III
spectrin’s scaffold of protein interactions is
disrupted
A, schematic diagram depicting identified interacting
partners of β-III spectrin: Arp1, ankyrin R, mGluR1
and EAAT4. B and B′, full-length (FL) EAAT4 located
at cell membrane and in spine-like protrusions when
overexpressed in Neuro2a cells. C and C′, EAAT4
lacking β-III spectrin’s interacting domain within
terminal 11 amino acids (EAAT411) is located
peri-nuclearly and in large intracellular vesicles. Scale
bar: B and C, 20 μm; B′ and C′, 10 μm.
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Table 3. Common Purkinje cell intrinsic activity defects in models of SCA
SCA subtype Physiological deficit Molecular mechanism
SCA1 Reduced intrinsic firing frequency. Irregular plateau
potential
Increased Kv4.3 surface expression
SCA2 Reduced intrinsic firing frequency Increased Ca2+ release from intracellular stores
SCA3 Purkinje cells either silent through depolarisation
block or display faster intrinsic firing rate/burst firing
Increased Kv3 channel inactivation
SCA5 Reduced intrinsic firing frequency Decrease in whole-cell and resurgent sodium current
SCA13 Reduced intrinsic firing frequency. Broader action
potential
Decrease in Kv3.3 activity
SCA27 Reduced intrinsic firing frequency Decrease in resurgent sodium
or Purkinje cells silent current
2010). Similarly, EAAT4 lacking the terminal 11 amino
acids and hence the β-III spectrin binding motif, remains
peri-nuclear or in large intracellular vesicular structures
when expressed in Neuro2a (Fig. 2C). In contrast full
length EAAT4 is present at the cell surface in Neuro2a
cells enriched in spine-like protrusions (Fig. 2B). Together
these in vitro findings support an important role for β-III
spectrin in the cellular trafficking and stabilisation of
EAAT4 at the plasma membrane. Importantly, reduced
EAAT4 levels were observed in young β-III−/− and
Spnb3−/− mice with EAAT4 accumulating in the cell soma
and dendritic shafts (Perkins et al. 2010; Stankewich et al.
2010; Gao et al. 2011), similar to SCA5 autopsy tissue
(Ikeda et al. 2006). Loss of EAAT4 and β-III spectrin
prior to onset of symptoms was also reported in a trans-
genic mouse model of SCA1 that specifically expresses
in Purkinje cells human ataxin-1 with a pathological
(82) polyglutamine repeat length (ATXN1Q82) (Lin et al.
2000; Serra et al. 2004). More direct evidence that
EAAT4 loss is causal in cerebellar dysfunction comes
from recent analyses of EAAT4 knockout animals which
were found to exhibit motor deficits prior to cerebellar
degeneration (unpublished data). No early loss of EAAT4
was observed in the SCA5 transgenic model, but this may
be a consequence of the low expression level of39 β-III
spectrin transgene (Armbrust et al. 2014).
Expression and stability of other membrane proteins
have also been reported to be dependent on β spectrin.
A decrease in two cell adhesion molecules, neuroglian
and Fasciclin II (Fas II), was observed in Drosophila
lacking presynaptic β spectrin (Pielage et al. 2005) and
an altered distribution of Fas II was seen in flies expressing
SCA5 mutant spectrin (Lorenzo et al. 2010). Recently
β-III spectrin repeats 14–16 were shown to interact with
the metabotropic glutamate receptor mGluR1α and TIRF
microscopy revealed wild-type but not mutant 39 β-III
spectrin could increase the stability of mGluR1α–green
fluorescent protein (GFP) at the plasma membrane
(Armbrust et al. 2014). The recruitment andmaintenance
of ankyrin R at the plasma membrane of Purkinje cell
dendrites also seems todependonβ-III spectrin (Clarkson
et al. 2014), and further direct evidence for the importance
of this interaction in SCA pathogenesis comes from
normoblastosis (nb/nb) mice, deficient in erythroid
ankyrin, which develop abnormal gait, tremor and 50%
loss of Purkinje cells by the age of 6 months (Peters et al.
1991).
β-III spectrin is not believed to be expressed in
Bergmann glia, but loss of the glial glutamate trans-
porter GLAST (EAAT1 in humans) was observed in
both Spnb3−/−(Stankewich et al. 2010) and β-III−/−
(Perkins et al. 2010) mouse lines, indicating an indirect
effect on glial membrane protein stability, possibly arising
from disruption to cell–cell adhesion and signalling
molecules. In β-III−/− mice the decrease in GLAST has
been implicated in the progression of motor deficits
(Perkins et al.2010andunpublisheddata) andcorrelations
between decreased GLAST expression and Purkinje cell
loss were also reported for transgenic ATXN1Q82 SCA1
mice (Cvetanovic, 2015) and mice expressing, only in
Bergmann glia, mutant ataxin 7 protein (Custer et al.
2006). Understanding the mechanisms that underpin loss
of GLAST will be important as these may highlight
potential strategies for mitigating disease progression.
There is also evidence that loss of EAAT1 is a primary cause
of ataxia with mutations in SLC1A3, the gene encoding
excitatory amino acid transporter 1, giving rise to episodic
ataxia (Jen et al. 2005; de Vries et al. 2009), further
supporting the idea that loss of GLAST is more than a
simple consequence of a different primary genetic defect.
Changes to intrinsic Purkinje cell activity. A key
component of Purkinje cell output is their intrinsic
activity, which has been found in in vitro electro-
physiological recordings to be altered in various SCA
models (Table 3 and Fig. 3). It is governed by specific
ion channels and in particular Nav1.1 and 1.6 channels,
the two dominant Nav channels in cerebellar Purkinje
neurons, bothofwhichpossess a resurgent sodiumcurrent
(Raman & Bean, 1997; Raman et al. 1997; Khaliq et al.
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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2003; Kalume et al. 2007). Sodium channel dysfunction
was observed in the β-III−/− mouse model of SCA5 prior
to cerebellar atrophywith smallerwhole-cell and resurgent
sodium currents recorded from dissociated Purkinje cells
isolated from P16–P20 β-III−/− mice (Fig. 4; Perkins
et al. 2010). This is consistent with the slower rate of
Purkinje cell tonic firing observed in cerebellar slices from
3-week-old β-III−/− mice (Fig. 3B; Perkins et al. 2010)
Normal firing frequency Silent
A
B
SCA3
10
 m
V
SCA1
SCA2
SCA3
SCA5
SCA13
SCA27
SCA27
500 ms
Slower firing frequency
Faster firing frequency
Burst firing
C
D
Figure 3. Intrinsic activity of Purkinje cells altered in
mouse models of SCA
A, representative trace of a current-clamp in vitro slice
recording for a spontaneously firing Purkinje cell. B, slower
firing rates compared to controls observed in models of
SCA1, 2, 5, 13 and 27. C, quiescent Purkinje cells identified
in SCA3 and 27 models, about one-half and 80% of cells,
respectively. D, faster tonic firing rate and burst firing
observed in remaining SCA3 tg/– Purkinje cells.
–90mV
A B
–90mV
–30mV
150 pA1 nA
10 ms
WT
β-III-/-
10 ms
–30mV
+30mV
Resurgent Na+ currentWhole cell Na+ current
Figure 4. Smaller sodium currents are likely to underpin reduced intrinsic activity
A, representative current traces from acutely dissociated Purkinje cells elicited with a step depolarisation to−30mV
from a holding potential of −90 mV. B, resurgent sodium currents evoked using a 20 ms step to +30 mV, from
a holding potential of –90 mV, followed by repolarisation to −30 mV. Top traces are from wild-type Purkinje cells
and bottom traces from β-III−/− Purkinje cells showing reduced whole cell Na+ currents and absence of resurgent
currents.
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and may well be a consequence of decreased Nav1.1 and
1.6 stability in the absence of a β-III spectrin/ankyrin R
anchor (Clarkson et al. 2014). Functional in vitro analyses
of two SCA5-associated mutant β-III spectrin proteins
(L253P and R634W) also showed diminished effects
in enhancing sodium currents compared to wild-type
β-III spectrin with reduced ankyrin R and Nav channel
levels associated with this effect (Clarkson et al. 2014).
Together the data indicate that reduced Purkinje cell
intrinsic activity due to a decreased stability of the β-III
spectrin/ankyrin-R/Nav complex is likely to be a critical
component of SCA5 pathogenesis. The heterozygous
R480W mutation associated with infantile ataxia was
found to have a similar effect to the L253P and R634W
mutants (Parolin Schnekenberg et al. 2015) and so
additional structural and expression studies are required
to resolve whether the change of arginine to tryptophan
at reside 480 is more physiologically deleterious than the
other heterozygous mutations so far characterised.
A similar decrease in Purkinje cell excitability resulting
from sodium channel dysfunction was reported for
SCA27 pathogenesis, the genetic causes of which are two
loss-of-function mutations, a point mutation (F145S) or
a frameshift mutation (Asp163fsX12), in the intracellular
fibroblast growth factor 14 (iFGF14) gene (Wang et al.
2002; van Swieten et al. 2003; Dalski et al. 2005). iFGFs
bind directly to the cytoplasmic C-terminal domains of
Nav channel α subunits, with wild-type FGF14 increasing
Nav current densities in hippocampal neurones (Lou et al.
2005), whereas peak sodium currents were reduced in cells
expressing SCA27 disease associated mutation FGF14F145S
(Laezza et al. 2007). It is thought that FGF14 functions as
an oligomeric protein and FGF14F145S acts as a dominant
negative disrupting the association of wild-type FGF14
and Nav channel α subunits. Such a role for loss-of-Nav
channel modulation and decreased neuronal excitability
in SCA27 pathogenesis is supported by the absence in
vitro of spontaneous activity in Purkinje cells both from
FGF14-null mice (Shakkottai et al. 2009), which exhibit
a very similar phenotype to that of SCA27 patients and
following in vivo iFGF14 knock-down studies (Bosch et al.
2015). Reduced Nav resurgent sodium current amplitudes
and spontaneous firing rates were also observed following
acute knockdownof iFGF14 in culturedPurkinje cells (Yan
et al.2014).Akey featureof SCA27pathogenesis appears to
be enhancedNav channel inactivation and loss of resurgent
current downstream of FGF14 loss-of-function.
Kv3 channels are also indispensable for high-frequency
intrinsic firing as they exhibit fast activation and
deactivationkinetics.Missensemutations (R420H,R423H
and F448L) in the gene encoding human Kv3.3 (KCNC3)
give rise to SCA13 (Waters et al. 2006; Irie et al.
2014). Since all Kv channels are formed by the assembly
of four subunits, Kv3.3 channels in SCA13 are likely
to consist of WT and mutant subunits with normal
function being disrupted in a dominant-negative manner.
This is supported by the fact smaller outward currents,
broadened action potential wave-forms and a reduced
firing frequency are observed in cultured Purkinje cells
expressing mouse Kv3.3–R424H (Irie et al. 2014), the
equivalent of human R423H, similar to in vitro recordings
from Kv3.3 knockout mice (Hurlock et al. 2008). The
resulting delay in Purkinje cell repolarisation is thought
to instigate cell death by increasing Ca2+ influx through
excessive activation of Cav channels.
Mutations giving rise to SCA19/22 were also recently
identified in another Kv subunit, Kv4.3, and are pre-
dicted to reduce cerebellar output, similar to SCA13,
as they impair trafficking of the channel to the plasma
membrane and/or reduce channel activity (Duarri et al.
2012; Lee et al. 2012). In contrast, accumulation of
Kv4.3 channels at the cell surface was observed in the
SCA1 ATXN1Q82 mouse model (Hourez et al. 2011).
Five-week-old ATXN1Q82 mice displayed impaired motor
performance and reduced in vitrofiring frequencies,with a
proportion of cells showing an irregular plateau potential,
but no cell atrophy or death at this age. Both the firing
frequency and the motor performance were restored by
Normal dendritic architecture
Abnormal dendritic architecture
sagittal coronal
A
B
Figure 5. Early morphological changes to Purkinje cell
dendritic architecture implicated in neuronal dysfunction
Individual Purkinje cells from 6-week-old WT (A) and β-III−/− (B)
animals filled with Alexa Fluor 568 and imaged at Nyquist sampling
rates (Scale bar, 20 μm). Thinner, disordered branching and greater
dendritic protrusion in coronal plane evident in Purkinje cells lacking
β-III spectrin. Morphological changes can result in changes to resting
membrane potential and number and/or specificity of synaptic
inputs.
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treatment with DiAP, a potassium channel blocker. The
molecular mechanisms underlying the increase in Kv4.3
surface expression and mode of DiAP action are not yet
fully understood, although the former is suggested to
be linked to reduced Kv internalisation due to smaller
glutamate receptor-mediated postsynaptic currents.
Alterations toPurkinje cell firingprior to signs of neuro-
degenerationwere also observed in in vitro slice recordings
formousemodels of SCA3with84glutamine repeats in the
ATXN3 gene (Shakkottai et al. 2011) and SCA2 with 127
glutamine repeats in human ataxin-2 cDNA (Hansen et al.
2013). About one half of the SCA3 tg/−Purkinje cells were
found to be silent, with a depolarisedmembrane potential
and the others either displayed a faster firing rate than
wild-type or exhibited repetitive bursts demonstrating
increased excitability (Fig. 3D). Depolarisation block,
through increased Kv3 current inactivation, was reported
to give rise to the loss of repetitive firing, but how
mutant ataxin-3 alters Kv3 channel kinetics is not known.
One possibility is that it affects the post-translational
modification of potassium channels. In the case of
ATXN2Q127 mice a progressive slowing in the firing rate
was observed with age but additional analyses are required
to determine the molecular mechanisms responsible.
Altered Purkinje cell dendritic architecture. Cerebellar
output is also influenced by the integration of excitatory
and inhibitory inputs that modulate intrinsic Purkinje
cell activity (Hausser & Clark, 1997). Since the elaborate
monoplanar Purkinje cell dendritic tree determines both
the number and type of input and how the synaptic signals
decay as they propagate towards the soma (Rall, 1977;
Hausser et al. 2000; Gulledge et al. 2005), alterations to
dendritic morphology will affect Purkinje cell output.
In young β-III−/− mice the Purkinje cell dendritic trees
were found to be disordered and no longer planar,
and dendrites were thinner (Fig. 5; Gao et al. 2011).
Membrane properties are affected by dendritic diameter
(Rall, 1977) and soaberrant activationof lowvoltage-gated
calcium channels and excessive calcium entry, a potential
consequence of thinner dendrites, may contribute to
neuronal dysfunction. Loss of planarity prior to cell death
can also alter synaptic inputs through interdigitation of
neighbouring dendritic trees.Multiple climbing fibre (CF)
C
B
Parallel fibre
stimulation WT β-III-/-
ascending
axons
A
Purkinje cell
recording
Normal
100 pA
20 ms
Hyperexcitable
granule
cells
Figure 6. Excessive glutamatergic innervation and AMPA receptor-mediated delayed excitotoxicity in
Purkinje cell degeneration
A, parallel fibre-mediated Purkinje cell postsynaptic excitatory currents (PF-EPSCs) measured by applying a
stimulus within the molecular layer. B, greater excitability in Purkinje cells from 3- to 6-week-old β-III−/− animals
compared to WT animals shown by larger PF-mediated EPSC amplitude. C, individually filled Purkinje cells reveal
dendritic degeneration and ultrastructural analysis using transmission electron microscopy demonstrates dark
cell degeneration in Purkinje cells from 8-month-old β-III−/− but not WT animals. Dilatation of endoplasmic
reticulum (ER), ER denuded of ribosomes (arrowhead) and fragmentation of Golgi (arrow) are all features of AMPA
receptor-elicited delayed excitotoxicity. Scale bar: top panel, 20 μm; bottom panel, 0.5 μm).
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innervation canarise viaCF transversebranches (Miyazaki
& Watanabe, 2011) and disruption to the specificity of
granule cell input can occur through ascending axons
making synaptic contact with more than one Purkinje
cell and/or parallel fibres making additional contacts with
the same Purkinje cell (Napper & Harvey, 1988).
Changes to Purkinje cell dendritic architecture were
also reported for Purkinje cells in an SCA3 mouse model
expressing N-terminally truncated ATXN3Q69 protein
(Konno et al. 2014) and for a cellular model of SCA14
(Seki et al. 2009), which is caused by missense mutations
in the PRKCG gene encoding protein kinase Cγ (PKCγ).
Expression of either mutant S119P or G128D PKCγ in
cultured Purkinje cells resulted in reduced dendritic area,
dendrite diameter and spine density (Seki et al. 2009).
Conventional PKCs require Ca2+ for activation and can
regulate actin cytoskeleton dynamics throughmodulation
of adducin and recruitment of spectrin to the ends of actin
filaments (Matsuoka et al. 1998). Morphological changes
could be a common feature in a number of SCAs due to
dysregulated Ca2+ homeostasis and downstream effects
on PKC activity and cytoskeletal dynamics.
Defects in glutamatergic neurotransmission. Purkinje
cells, due to the large amount of afferent glutamatergic
input they receive from both parallel and climbing fibres
through activation of ionotropic AMPA andmetabotropic
(mGluRs) receptors, are especially vulnerable to
glutamate-mediated excitotoxicity and elevations in intra-
cellular calcium (Fig. 6). Aberrant glutamatergic neuro-
transmission has been observed in two of the SCA5mouse
models. Enhanced parallel fibre-mediated excitatory post-
synaptic currents (PF-EPSCs) were recorded from young
β-III−/− mice compared to wild-type mice (Fig. 6A and
B; Perkins et al. 2010). Although initially the increase
in excitability is thought to partially offset the reduced
spontaneous activity, the excessive activation of AMPA
receptors would appear to be ultimately detrimental,
with Purkinje cells from 8-month and older animals
found to exhibit dendritic degeneration, undergo dark cell
degeneration (Fig. 6C) and have reduced in vivo output
(Perkins et al. 2010).
The glutamatergic defect detected in the SCA5 trans-
genic model is reducedmGluR1 activity following parallel
fibre stimulation, due to mislocalisation but not loss of
mGluR1 protein (Armbrust et al. 2014). Impairment of
mGluR1 signalling was also reported in the ATXN3Q69
mouse model (Konno et al. 2014). A similar loss of
mGluR1 signalling may not be detected in the two SCA5
knock-out models as unlike the transgenic animals they
both exhibit a loss of EAAT4 protein. EAAT4 modulates
the activation of perisynaptic mGluRs, with high EAAT4
expressing Purkinje cells exhibiting very little mGluR
activity (Wadiche& Jahr, 2005). Loss of EAAT4 in Spn3−/−
and β-III−/−, as well as ATXN1Q82 mice may therefore
result in excessive mGluR activation and downstream
dysregulated calcium homeostasis. This would be similar
to recent findings in a mouse model of SCA28, which
is haploinsufficient for Afg3l2 and displays dark cell
degeneration of Purkinje cells (Maltecca et al. 2009).
Reducing mGluR1 activity was found to decrease Ca2+
levels in Afg3l2+/− Purkinje cells and reverse the ataxic
phenotype (Maltecca et al. 2015) indicating attenuating
mGluR1 signalling may possess therapeutic promise.
The generation and analyses of various SCA mouse
models has revealed possible common physiological
deficits downstream of different primary genetic defects.
Alterations to intrinsic firing through either direct or
indirect effects on ion channels critical for maintaining
fast repetitive Purkinje cell firing have been observed
in the early stages of cerebellar ataxia in a number of
SCA models. The majority of these studies have utilised
in vitro slice recordings and so in the future it may
be informative to assess the cerebellar output in awake
animals. Alterations to Purkinje cell Ca2+ homeostasis, in
a number of instances arising from altered glutamatergic
transmission, are another mechanism common across
SCAswhich could contribute to dysregulated PKCactivity,
cytoskeletal alterations, aberrant dendritic architecture
and ultimately cell death.
Summary
Cerebellar ataxias can all be characterised by the same
clinical features (postural abnormalities, progressive
motor incoordination and cerebellar degeneration)
highlighting that although the underlying primary genetic
defects differ, the downstream molecular mechanisms
are likely to converge, with the ultimate effect of altered
cerebellar output being common to all. Studies outlined in
this review have identified alterations to intrinsic Purkinje
cell excitability, dendritic morphology and glutamatergic
transmission, arising from disruption to membrane
protein trafficking, localisation and stabilisation, as factors
pertinent to altered cerebellar output following loss of
β-III spectrin function. The necessity for orchestration
of protein networks in normal cerebellar physiology is
exemplified by the disruption of β-III spectrin function
anddemonstrates how it is possible that defects indifferent
components of a protein network can instigate the same
pathogenic pathway.
Given that motor and cognitive decline are associated
with normal ageing, a key question is whether changes
to the spectrin submembranous meshwork and key
membrane proteins might underpin age-related changes
in performance. It has been reported that a progressive
increase in α-II spectrin proteolysis (Cai et al. 2012;
Hwang et al. 2012), a calcium-dependent process linked to
Purkinje cell toxicity (Mansouri et al. 2007), is associated
with age. Dilatation of the endoplasmic reticulum and
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degeneration of the Golgi apparatus (Dlugos, 2005),
reduction in glutamate transporters and functional
glutamate uptake associated with mGluR activation
(Potier et al. 2010; Brothers et al. 2013; Pereira et al.
2014) as well as changes to the distribution of Nav
channels (Chung et al. 2003) have also all been reported
in aged rodents. Dysregulation of glutamatergic neuro-
transmission and Purkinje cell excitability may therefore
be an important feature of age-related cerebellar decline.
Similarly cerebellar abnormalities have also been linked
to the pathophysiology of Alzheimer’s disease (Sjo¨beck
& Englund, 2001; Mavroudis et al. 2013), schizophrenia
(Andreasen & Pierson, 2008), autism (Courchesne et al.
1994; Palmen et al. 2004; Whitney et al. 2008) and other
cognitive and neuropsychiatric disorders (Schmahmann
& Sherman, 1998; Konarski et al. 2005; Alalade et al.
2011; Stoodley & Stein 2011). The ongoing challenge
for researchers will be to decipher subtle changes in the
morphological and molecular integrity of the cerebellar
cortex that underpin Purkinje cell dysfunction both in
early stages of various neurological disorders and in
normal ageing.
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